Mintek LV-T Pacemaker User Manual


 
Stratos LV/LV-T Technical Manual 19
Clinical Inclusion Criteria
To support the objectives of this investigation, patients were
required to meet the following inclusion criteria prior to
enrollment:
Meet the indications for therapy
Persistent (documented for more than 7 days),
symptomatic AF with poorly controlled rapid ventricular
rates or permanent, (documented for more than 30 days
with failed cardioversion, or longstanding AF of 6 months
or more) symptomatic AF with poorly controlled rapid
ventricular rates.
Eligible for AV nodal ablation and permanent pacemaker
implantation
NYHA Class II or III heart failure
Age 18 years
Understand the nature of the procedure
Ability to tolerate the surgical procedure required for
implantation
Give informed consent
Able to complete all testing required by the clinical
protocol
Available for follow-up visits on a regular basis at the
investigational site